
Xavier Matias-Guiu Guia
Grado: Doctor/a
973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat
ResearcherID: http://www.researcherid.com/rid/C-3039-2009
Grupos
Publicaciones
-
Vidal, D; Matias-Guiu, X; Alomar, A
Efficacy of imiquimod for the expression of Bcl-2, Ki67, p53 and basal cell carcinoma apoptosis
BRITISH JOURNAL OF DERMATOLOGY 151 656-662. .
-
Toll, A; Gilaberte, M; Matias-Guiu, X; Camacho, L; Alomar, A; Gonzalez-Gay, MA; Pujol, RM
Kikuchi's disease (necrotizing lymphadenitis) with cutaneous involvement associated with subacute cutaneous lupus erythematosus
CLINICAL AND EXPERIMENTAL DERMATOLOGY 29 240-243. .
-
Moreno-Bueno, G; Hardisson, D; Prat, J; Matias-Guiu, J; Palacios, J
Re: Scholten et al. nuclear beta-catenin is a molecular feature of type I endometrial carcinoma. J Pathol 2003; 201 : 460-465
JOURNAL OF PATHOLOGY 202 511-512. .
-
Trovisco, V; de Castro, IV; Soares, P; Maximo, V; Silva, P; Magalhaes, J; Abrosimov, A; Guiu, XM; Sobrinho-Simoes, M
BRaF mutations are associated with some histological types of papillary thyroid carcinoma
JOURNAL OF PATHOLOGY 202 247-251. .
-
Valenzuela, N; Barnadas, MA; Matias-Guiu, X; Curell, R; de Andres, L; Alomar, A
Lethal perianal Buschke-Lowenstein tumor in a female patient with aIDS
Dermatology 208 349-350. .
-
Pallares, J; Perez-Ruiz, L; Ros, S; Panades, J; Pardo-Mindan, J; Lloreta, J; Matias-Guiu, X
Malignant peripheral nerve sheath tumor of the thyroid: a clinicopathological and ultrastructural study of one case.
ENDOCRINE PATHOLOGY 15 167-174. .
-
Moreno-Bueno, G; Sanchez-Estevez, C; Cassia, R; Rodriguez-Perales, S; Diaz-Uriarte, R; Dominguez, O; Hardisson, D; Andujar, M; Prat, J; Matias-Guiu, X; Cigudosa, JC; Palacios, J
Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas
CANCER RESEARCH 63 5697-5702. .
-
Alvarez-Nunez, F; Mora, J; Matias-Guiu, X; Grp Estudio Marcadores Tumorales
Thyroid carcinomas of the follicular epithelium: tumor markers and oncogenes
MEDICINA CLINICA 121 264-269. .
-
Moreno-Bueno, G; Rodriguez-Perales, S; Sanchez-Estevez, C; Hardisson, D; Sarrio, D; Prat, J; Cigudosa, JC; Matias-Guiu, X; Palacios, J
Cyclin D1 gene (CCND1) mutations in endometrial cancer
ONCOGENE 22 6115-6118. .
-
Bellido, M; Aventin, A; Lasa, A; Estivill, C; Carnicer, MJ; Pons, C; Matias-Guiu, X; Bordes, R; Baiget, M; Sierra, J; Nomdedeu, JF
Id4 is deregulated by a t(6;14)(p22;q32) chromosomal translocation in a B-cell lineage acute lymphoblastic leukemia
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 88 994-1001. .
-
Ota, S; Catasus, L; Matias-Guiu, X; Bussaglia, E; Lagarda, H; Pons, C; Munoz, J; Kamura, T; Prat, J
Molecular pathology of atypical polypoid adenomyoma of the uterus
HUMAN PATHOLOGY 34 784-788. .
-
Moreno-Bueno, G; Hardisson, D; Sarrio, D; Sanchez, C; Cassia, R; Prat, J; Herman, JG; Esteller, M; Matias-Guiu, X; Palacios, L
Abnormalities of E- and P-cadherin and catenin (beta-, gamma-catenin, and p120(ctn)) expression in endometrial cancer and endometrial atypical hyperplasia
JOURNAL OF PATHOLOGY 199 471-478. .
Proyectos
- Unravelling the molecular and phenotypic complexity of endometriosis through new models and omics integration: towards a personalized clinical management
- Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
- EPH Receptor Signaling in Endometrial Cancer
- Ajuts per a la contractació de personal investigador novell (FI)
- Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
- "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
- EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
- Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
- CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
- DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
- Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
- VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU